These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24680120)

  • 41. Frequency of malignancy in lesions classified as probably benign after dynamic contrast-enhanced breast MRI examination.
    Sadowski EA; Kelcz F
    J Magn Reson Imaging; 2005 May; 21(5):556-64. PubMed ID: 15834907
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
    Kuhl CK; Schild HH; Morakkabati N
    Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [MR imaging of the breast before and after neoadjuvant treatment - enhancement characteristics and T 2 signal intensity of breast cancers and breast parenchyma].
    Siegmann KC; Müller KT; Vogel U; Krauss K; Claussen CD
    Rofo; 2010 Jun; 182(6):493-500. PubMed ID: 19953430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Breast magnetic resonance imaging: management of an enhancing focus.
    Ha R; Comstock CE
    Radiol Clin North Am; 2014 May; 52(3):585-9. PubMed ID: 24792658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Magnetic resonance imaging of the breast in evaluating residual diseases at lumpectomy site soon after excisional biopsy.
    Yang H; Liu H; Peng W; Hua Y
    J Comput Assist Tomogr; 2012; 36(2):196-9. PubMed ID: 22446359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Breast MRI in the evaluation of locally recurrent or new breast cancer in the postoperative patient: correlation of morphology and enhancement features with the BI-RADS category.
    Seely JM; Nguyen ET; Jaffey J
    Acta Radiol; 2007 Oct; 48(8):838-45. PubMed ID: 17851971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcome of high-risk lesions at MRI-guided 9-gauge vacuum- assisted breast biopsy.
    Heller SL; Elias K; Gupta A; Greenwood HI; Mercado CL; Moy L
    AJR Am J Roentgenol; 2014 Jan; 202(1):237-45. PubMed ID: 24370150
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Small masses on breast MR: is biopsy necessary?
    Raza S; Sekar M; Ong EM; Birdwell RL
    Acad Radiol; 2012 Apr; 19(4):412-9. PubMed ID: 22277636
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BI-RADS® 3 lesions at contrast-enhanced breast MRI: is an initial short-interval follow-up necessary?
    Bahrs SD; Baur A; Hattermann V; Hahn M; Vogel U; Claussen CD; Siegmann-Luz KC
    Acta Radiol; 2014 Apr; 55(3):260-5. PubMed ID: 23969262
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serial MR imaging of small arterially-enhancing liver lesions in patients with chronic liver disease.
    Korpraphong P; Leyendecker JR; Hildebolt CF; Narra V; Bae KT; Brown JJ
    J Med Assoc Thai; 2009 Apr; 92(4):548-55. PubMed ID: 19374308
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathologic correlates of false positive breast magnetic resonance imaging findings: which lesions warrant biopsy?
    Langer SA; Horst KC; Ikeda DM; Daniel BL; Kong CS; Dirbas FM
    Am J Surg; 2005 Oct; 190(4):633-40. PubMed ID: 16164938
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contralateral lesions detected by preoperative MRI in patients with recently diagnosed breast cancer: application of MR CAD in differentiation of benign and malignant lesions.
    Cho N; Kim SM; Park JS; Jang M; Kim SY; Chang JM; Moon WK
    Eur J Radiol; 2012 Jul; 81(7):1520-6. PubMed ID: 21498016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Survival outcomes of breast cancer patients who receive neoadjuvant chemotherapy: association with dynamic contrast-enhanced MR imaging with computer-aided evaluation.
    Yi A; Cho N; Im SA; Chang JM; Kim SJ; Moon HG; Han W; Park IA; Noh DY; Moon WK
    Radiology; 2013 Sep; 268(3):662-72. PubMed ID: 23592770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pancreatic cysts 3 cm or smaller: how aggressive should treatment be?
    Sahani DV; Saokar A; Hahn PF; Brugge WR; Fernandez-Del Castillo C
    Radiology; 2006 Mar; 238(3):912-9. PubMed ID: 16439566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Malignancy rates of non-masslike enhancement on breast magnetic resonance imaging using American College of Radiology Breast Imaging Reporting and Data System descriptors.
    Wilhelm A; McDonough MD; DePeri ER
    Breast J; 2012; 18(6):523-6. PubMed ID: 23009294
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcome of MRI-guided breast biopsy.
    Han BK; Schnall MD; Orel SG; Rosen M
    AJR Am J Roentgenol; 2008 Dec; 191(6):1798-804. PubMed ID: 19020252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Accuracy of breast magnetic resonance imaging in predicting pathologic response in patients treated with neoadjuvant chemotherapy.
    De Los Santos J; Bernreuter W; Keene K; Krontiras H; Carpenter J; Bland K; Cantor A; Forero A
    Clin Breast Cancer; 2011 Oct; 11(5):312-9. PubMed ID: 21831721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Breast MRI using the VIBE sequence: clustered ring enhancement in the differential diagnosis of lesions showing non-masslike enhancement.
    Tozaki M; Igarashi T; Fukuda K
    AJR Am J Roentgenol; 2006 Aug; 187(2):313-21. PubMed ID: 16861532
    [TBL] [Abstract][Full Text] [Related]  

  • 59. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement.
    Gutierrez RL; DeMartini WB; Eby PR; Kurland BF; Peacock S; Lehman CD
    AJR Am J Roentgenol; 2009 Oct; 193(4):994-1000. PubMed ID: 19770321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience.
    Orel SG; Rosen M; Mies C; Schnall MD
    Radiology; 2006 Jan; 238(1):54-61. PubMed ID: 16304093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.